Four-Drug attack aims to shrink 'Unremovable' tumors for Life-Saving surgery
NCT ID NCT07433673
Summary
This study is testing if adding an immunotherapy drug called cemiplimab to a standard three-drug chemotherapy regimen can shrink tumors in patients with locally advanced, inoperable bile duct cancer. The main goal is to see if this four-drug combination can shrink the tumors enough so that surgery to remove them becomes possible, which is currently the only potential cure. The trial is enrolling about 20 adults who have not had prior treatment for this specific cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON AND RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.